European Archives - Page 76 of 1607 - European Medical Journal

ESHRE 2026 Interview: Anis Feki

The central challenge is inequity. Across Europe, access to fertility care still depends too heavily on where people live, on funding…

Memory B Cells Predicted BCG Response in Bladder Cancer

Higher pretreatment memory B cell infiltration and mature tertiary lymphoid structures were associated with improved BCG response and longer recurrence free survival in patients with non muscle invasive bladder cancer.

MHRA Approves Nerandomilast for Pulmonary Fibrosis

The MHRA has approved nerandomilast for adults with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis, expanding treatment options in the UK.

Kaposi Sarcoma Relapse Reported Despite HIV Viral Control

Kaposi sarcoma relapse was observed in people living with HIV despite viral suppression, with chemotherapy responses seen in a small prospective cohort.

ESHRE 2026 Interview: Karen Sermon

I think whole genome sequencing is probably the next major step. Once you’re analysing an embryo, it becomes technically possible to look…

Serum REG3α Enhances Ulcerative Colitis Disease Activity Detection

A prospective study suggests the serum REG3α biomarker is associated with clinical and endoscopic activity in ulcerative colitis and may complement C reactive protein testing.

Kaposi Sarcoma Risk in People with HIV Linked to MAVS Gene Variant

A genome-wide association study identified a MAVS gene variant associated with Kaposi sarcoma in people living with HIV, highlighting inherited susceptibility.

ALD Diagnosis Triggers Early Reduction in Alcohol Use

A diagnosis of alcohol-related liver disease prompted many patients to reduce or stop drinking, although more than one-third relapsed within three months.

Novel Procedure Shows Promise for Giant Lung Bullae

A new percutaneous aspiration sclerotherapy technique improved lung function and quality of life in COPD patients with giant pulmonary bullae.

Zinc Oxide Nanoparticles Show Promise Against MRSA Biofilms

Zinc oxide nanoparticles demonstrated potent antibacterial and anti-biofilm activity against MRSA isolates, suggesting a promising approach for tackling antimicrobial resistance.